Search Results - "Sehdev, Sandeep"

Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada.

Authors: Jerzak, Katarzyna J. Sehdev, Sandeep Boileau, Jean-François et al.

Source: Current Oncology. Aug2025, Vol. 32 Issue 8, p444. 19p.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2− Early Breast Cancer 2025.

Authors: Sehdev, Sandeep Joy, Anil Abraham Boileau, Jean-François et al.

Source: Current Oncology. Feb2026, Vol. 31 Issue 2, p112. 38p.

Impact of Systemic Delays for Patient Access to Oncology Drugs on Clinical, Economic, and Quality of Life Outcomes in Canada: A Call to Action.

Authors: Sehdev, Sandeep Gotfrit, Joanna Elias, Martine et al.

Source: Current Oncology. Mar2024, Vol. 31 Issue 3, p1460-1469. 10p.

Correction to: Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.

Authors: Papp, Kim A. Melosky, Barbara Sehdev, Sandeep et al.

Source: Dermatology & Therapy. Aug2023, Vol. 13 Issue 8, p1889-1890. 2p.

Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement †.

Authors: Sehdev, Sandeep R. Rawson, Nigel S. B. Aseyev, Olexiy I. et al.

Source: Current Oncology. Apr2024, Vol. 31 Issue 4, p1803-1816. 14p.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).

Authors: Kumar, Aalok Jerzak, Katarzyna J. Gelmon, Karen A. et al.

Source: Current Oncology. Apr2026, Vol. 33 Issue 4, p200. 25p.

Author Index, 2018 CUA Abstracts.

Source: Canadian Urological Association Journal. 2018 Supplement, Vol. 12, pS137-S144. 8p.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.

Authors: Simmons, Christine Khan, Omar F. Brezden-Masley, Christine et al.

Source: Current Oncology. May2026, Vol. 33 Issue 5, p243. 38p.

Sunitinib toxicity management -- a practical approach.

Authors: Sehdev, Sandeep¹

Source: Canadian Urological Association Journal. Nov/Dec2016 Supplement 2, pS248-S251. 4p.

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29 , 9891–9895"

Authors: Rayson, Daniel Gandhi, Sonal Joy, Anil A. et al.

Source: Current Oncology. May2023, Vol. 30 Issue 5, p5050-5053. 4p.

Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to Action.

Authors: Weber, Evan Carmona-Gonzalez, Carlos A. Boucher, Melanie et al.

Source: Current Oncology. Jun2025, Vol. 32 Issue 6, p290. 19p.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2− Metastatic Breast Cancer 2025.

Authors: Jerzak, Katarzyna J. Kumar, Aalok Boileau, Jean-François et al.

Source: Current Oncology. Feb2026, Vol. 31 Issue 2, p106. 36p.

Is It Time to Commit to a Process to Re-Evaluate Oncology Drugs? A Descriptive Analysis of Systemic Therapies for Solid Tumour Indications Reviewed in Canada from 2017 to 2021.

Authors: Sehdev, Sandeep Chambers, Alexandra

Source: Current Oncology. Mar2022, Vol. 29 Issue 3, p1919-1931. 13p. 1 Diagram, 7 Graphs.

Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.

Authors: Papp, Kim A. Melosky, Barbara Sehdev, Sandeep et al.

Source: Dermatology & Therapy. Apr2023, Vol. 13 Issue 4, p867-889. 23p.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer.

Authors: Cao, Jeffrey Q. Surgeoner, Brae Manna, Mita et al.

Source: Current Oncology. Nov2024, Vol. 31 Issue 11, p7226-7243. 18p.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting.

Authors: Manna, Mita Gelmon, Karen A. Boileau, Jean-François et al.

Source: Current Oncology. Nov2024, Vol. 31 Issue 11, p6536-6567. 32p.

A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer.

Authors: McGee, Sharon F. Clemons, Mark Pond, Gregory et al.

Source: Current Oncology. Aug2024, Vol. 31 Issue 8, p4531-4545. 15p.

Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic.

Authors: Tse, Tabitha Sehdev, Sandeep Seely, Jean et al.

Source: Current Oncology. Apr2021, Vol. 28 Issue 2, p1338-1347. 10p.

New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices.

Authors: Stewart, David J. Bradford, John-Peter Sehdev, Sandeep et al.

Source: Current Oncology. May2024, Vol. 31 Issue 5, p2453-2480. 28p.

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain.

Authors: Rayson, Daniel Gandhi, Sonal Joy, Anil A. et al.

Source: Current Oncology. Dec2022, Vol. 29 Issue 12, p9891-9895. 5p.